Category Archives: TRIPS flexibilities

Indian Civil Society letter on TB Declaration negotiations -UN High Level Meeting

To, Mr. Narendra Modi, Prime Minister of India Mr. J. P. Nadda, Health Minister Ms. Sushma Swaraj, Foreign Minister Mr. Suresh Prabhu, Commerce Minister Date: 31st July 2018 Sub: Asking India to support TRIPS flexibilities in UN High Level Meeting on TB … Continue reading

Posted in Access to Medecines, Delinkage, R&D, TRIPS, TRIPS flexibilities, Tuberculosis (TB), Uncategorized | Leave a comment

Here’s the short note on UNHLM on TB and US pressurising to dilute TRIPS flexibilities

The United Nations is going to hold a High Level Meeting on TB in New York in September. The member countries of UN will sign on a declaration will set the direction in which work on TB, globally, will move. … Continue reading

Posted in TRIPS, TRIPS flexibilities, Tuberculosis (TB), US Pressure | Leave a comment

Document exclusivity weakens Norwegian pandemic preparedness

Source: Dagens Medisin | June 20, 2018 IMAGINE THAT A large global o, break of contagious disease also includes Norway, such as a new flu-like disease with high risk of transmission and mortality. Imagine that there is only one effective drug, … Continue reading

Posted in Compulsory Licensing, Patent, Patents | Leave a comment

WIPO: Proposal to amend PCT Regulations undermines TRIPS flexibilities

Geneva, 15 June (TWN) – A proposal to amend a treaty regulation at the World Intellectual Property Organization (WIPO) will compromise TRIPS flexibilities, especially in relation to the scope of patentability for national patent offices. The International Bureau (i.e. WIPO … Continue reading

Posted in Patent, TRIPS, TRIPS flexibilities, TRIPS plus, TRIPS&IP rights, Uncategorized, WIPO | Leave a comment

WHO: Proposed work program on “fair price” undermines affordability of medicines

Source: The Third World Network | May 21, 2018 by KM Gopakumar Geneva:  The proposed work program on fair price raises concerns on affordability of medicines. The document was prepared by the Secretariat of the World Health Organization (WHO)for the … Continue reading

Posted in Access to Medecines, Drug prices, Pricing, TRIPS, TRIPS flexibilities, Uncategorized | Leave a comment

Prices of Patented Medicines in India

Source: Economic & Political Weekly | Vol. 53, Issue No. 22, 02 Jun, 2018 by Sharmila Mary Joseph  & James J Nedumpara To Regulate or Not to Regulate? Medicines with valid patents generally enjoy exemption from price regulation in most countries. In India, … Continue reading

Posted in Access to Medecines, Doha Declaration, Patent, Patents, TRIPS, TRIPS flexibilities, TRIPS plus, TRIPS&IP rights, Uncategorized | Leave a comment

For the first time the court has allowed the Russian pharmaceutical companies to produce a similar drug from USA

Source: HandofMoscow | June 3, 2018 by Andry Kut The arbitration court of Moscow satisfied the request of the Russian pharmaceutical company “Ukrenergo” on the issuance of a license to use a patent of the American Corporation Celgene in connection with a … Continue reading

Posted in Compulsory Licensing, Uncategorized | Leave a comment